Feng‐Bin Lu
Impact in
- Hepatology top 5%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
Papers in
-
- Liver Diseases and Immunity 3
-
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Lanman Xu (7 shared papers)En-De Hu (7 shared papers)Ming‐Hua Zheng (6 shared papers)Da‐Zhi Chen (6 shared papers)Jinlu Wu (6 shared papers)Yongping Chen (6 shared papers)Yong‐Ping Chen (2 shared papers)Zhuo Lin (4 shared papers)
In The Last Decade
Feng‐Bin Lu
12 papers receiving 758 citations
Peers
Comparison fields: 5 of 78
- Hepatology 138
- Epidemiology 327
- Cancer Research 138
- Endocrinology, Diabetes and Metabolism 116
- Molecular Biology 285
Countries citing papers authored by Feng‐Bin Lu
This map shows the geographic impact of Feng‐Bin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Bin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Bin Lu more than expected).
Fields of papers citing papers by Feng‐Bin Lu
This network shows the impact of papers produced by Feng‐Bin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Bin Lu. The network helps show where Feng‐Bin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng‐Bin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 200 | |
| 2 | 2018 | 119 | |
| 3 | 2020 | 94 | |
| 4 | 2018 | 83 | |
| 5 | 2018 | 80 | |
| 6 | 2019 | 62 | |
| 7 | 2017 | 34 | |
| 8 | 2024 | 26 | |
| 9 | 2018 | 24 | |
| 10 | 2020 | 21 | |
| 11 | [Effect of lycopene on oxidative stress and behavioral deficits in rotenone induced model of Parkinson's disease]. | 2013 | 20 |
| 12 | 2018 | 7 | |
| 13 | 2025 | 0 |
About Feng‐Bin Lu
Feng‐Bin Lu is a scholar working on Hepatology, Epidemiology, Pharmacology, Cancer Research and Rheumatology, having authored 13 papers that have together received 770 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Liver Diseases and Immunity (3 papers), Extracellular vesicles in disease (2 papers), Diet, Metabolism, and Disease (1 paper), Circular RNAs in diseases (1 paper), Drug Transport and Resistance Mechanisms (1 paper), Coffee research and impacts (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Hepatology (138 citations), Epidemiology (327 citations), Cancer Research (138 citations), Endocrinology, Diabetes and Metabolism (116 citations) and Molecular Biology (285 citations). Feng‐Bin Lu has collaborated with scholars based in China, Canada and Italy. Frequent co-authors include Lanman Xu, En-De Hu, Ming‐Hua Zheng, Da‐Zhi Chen, Jinlu Wu, Yongping Chen, Yong‐Ping Chen, Zhuo Lin, Xiaoya Jin and Yuewen Gong. Their work appears in journals such as Hepatology International, Molecular Immunology, BMC Medical Genomics, European Journal of Gastroenterology & Hepatology and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.